Cargando…

QOL-22. MACHINE-LEARNING INFERENCE MAY PREDICT QUALITY OF LIFE SUBGROUPS OF ADAMANTINOMATOUS CRANIOPHARYNGIOMA

BACKGROUND: Due to disease and/or treatment-related injury, such as hypothalamic, visual, and endocrine damage, quality of life (QoL) scores after childhood-onset Adamantinomatous Craniopharyngioma (ACP) are among the lowest of all pediatric brain tumors. Decision-making regarding management would b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hengartner, Astrid C, Prince, Eric, Staulcup, Susan, Vijmasi, Trinka, Souweidane, Mark, Jackson, Eric M, Johnston, James M, Anderson, Richard C E, Naftel, Robert P, Grant, Gerald, Niazi, Toba N, Dudley, Roy, Limbrick, David D, Ginn, Kevin, Smith, Amy, Kilburn, Lindsay, Jallo, George, Wilkening, Greta, Hankinson, Todd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Neuropsychology/Quality of Life
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715913/ http://dx.doi.org/10.1093/neuonc/noaa222.684

Ejemplares similares

RARE-11. QUANTITATIVE MR IMAGING FEATURES ASSOCIATED WITH UNIQUE TRANSCRIPTIONAL CHARACTERISTICS IN PEDIATRIC ADAMANTINOMATOUS CRANIOPHARYNGIOMA: A POTENTIAL GUIDE FOR THERAPY
por: Mirsky, David, et al.
Publicado: (2020)

Transcriptional analyses of adult and pediatric adamantinomatous craniopharyngioma reveals similar expression signatures regarding potential therapeutic targets
por: Prince, Eric, et al.
Publicado: (2020)

RARE-10. ADAMANTINOMATOUS CRANIOPHARYNGIOMA RESIDES OUTSIDE THE BLOOD BRAIN BARRIER
por: Prince, Eric, et al.
Publicado: (2020)

RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response
por: Trudeau, Tammy, et al.
Publicado: (2022)

MODL-24. AN ORGANOTYPIC CHUNK CULTURE TECHNIQUE TO STUDY DISEASE MECHANISM AND DEVELOP TARGETED THERAPEUTICS FOR PEDIATRIC ADAMANTINOMATOUS CRANIOPHARYNGIOMA
por: Vijmasi, Trinka, et al.
Publicado: (2020)

Robust deep learning classification of adamantinomatous craniopharyngioma from limited preoperative radiographic images
por: Prince, Eric W., et al.
Publicado: (2020)

RARE-08. CYST FLUID CYTOKINES MAY PROMOTE EPITHELIAL-TO-MESENCHYMAL TRANSITION IN PEDIATRIC ADAMANTINOMATOUS CRANIOPHARYNGIOMA
por: Vijmasi, Trinka, et al.
Publicado: (2020)

QOL-37. USE OF COMPUTERIZED NEUROPSYCHOLOGICAL MEASURES TO ASSESS COGNITIVE MORBIDITY IN CHILDREN UNDERGOING ACTIVE RADIATION THERAPY
por: Kais, Lorri, et al.
Publicado: (2020)

QOL-38. USE OF COMPUTERIZED NEUROPSYCHOLOGICAL MEASURES TO ASSESS COGNITIVE MORBIDITY IN SURVIVORS OF CHILDHOOD BRAIN TUMORS
por: Dickson, Duncan, et al.
Publicado: (2020)

RARE-19. NETWORK AND DEEP LEARNING INFERENCE IN SINGLE CELL RNA SEQUENCING REVEAL DETAILED TRANSCRIPTIONAL SIGNATURES CONGRUENT WITH MOLECULAR UNDERSTANDING OF ADAMANTINOMATOUS CRANIOPHARYNGIOMA
por: Prince, Eric, et al.
Publicado: (2021)

Adamantinomatous craniopharyngioma associated with a compromised blood–brain barrier: patient series
por: Prince, Eric W., et al.
Publicado: (2021)

QOL-40. THE IMPACT OF TASK COMPLEXITY ON INFORMATION PROCESSING SPEED AND NEURAL COMMUNICATION IN PAEDIATRIC BRAIN TUMOUR SURVIVORS
por: Cox, Elizabeth, et al.
Publicado: (2020)

QOL-06. QUALITY OF LIFE IN MEDULLOBLASTOMA SURVIVORS IN WESTERN MEXICO
por: del Campo, Regina M Navarro-Martin, et al.
Publicado: (2020)

QOL-27. SWALLOWING ASSESSMENT IN PEDIATRIC PATIENTS WITH BRAIN TUMOR
por: Machado, Natalia Oliveira, et al.
Publicado: (2020)

QOL-43. ENDOCRINE AND METABOLIC CHANGES IN CHILDREN TREATED FOR MEDULLOBLASTOMA
por: Kalinin, Alexey, et al.
Publicado: (2020)

QOL-48. INTERDISCIPLINARY SPIRITUAL CARE TRAINING IN PEDIATRIC NEURO-ONCOLOGY
por: Lion, Alex, et al.
Publicado: (2020)

QOL-58. ASSESSING FATIGUE EXPERIENCED BY PEDIATRIC PATIENTS WITH INTRACRANIAL NEOPLASMS
por: Eccles, Eamon, et al.
Publicado: (2020)

QOL-41. CARDIAC DYSFUNCTION IN MEDULLOBLASTOMA SURVIVORS TREATED WITH PHOTON IRRADIATION
por: Cacciotti, Chantel, et al.
Publicado: (2020)

QOL-01. LONGITUDINAL COMPARISON OF NEUROCOGNITIVE TRAJECTORIES IN PEDIATRIC MEDULLOBLASTOMA PATIENTS TREATED WITH PROTON VERSUS PHOTON RADIOTHERAPY
por: Kahalley, Lisa, et al.
Publicado: (2020)

RARE-32. Phase 0 and feasibility single-institution clinical trial of intravenous tocilizumab for adamantinomatous craniopharyngioma
por: Dorris, Kathleen, et al.
Publicado: (2022)

QOL-15. NEURAL NETWORK INTEGRITY FOR FACIAL AFFECT RECOGNITION IN SURVIVORS OF MEDULLOBLASTOMA
por: Brinkman, Tara, et al.
Publicado: (2020)

QOL-05. TUMOR LOCATION IS LESS LIKELY INFLUENCE ON COGNITIVE DYSFUNCTION IN CHILDREN
por: Nakajima, Riho, et al.
Publicado: (2020)

QOL-36. USE OF CANNABINOIDS IN THE PEDIATRIC CENTRAL NERVOUS SYSTEM TUMOR POPULATION
por: Dorris, Kathleen, et al.
Publicado: (2020)

QOL-28. NEUROCOGNITIVE PROFILE OF PEDIATRIC MEDULLOBLASTOMA PATIENTS PRIOR TO RADIATION THERAPY
por: Baig, Muhammad, et al.
Publicado: (2020)

QOL-56. THE RELAPSED AND OR PROGRESSED BRAIN TUMOURS IN CHILDREN: RHC, GLASGOW EXPERIENCE
por: Sastry, Jairam, et al.
Publicado: (2020)

QOL-54. HEIGHT, WEIGHT AND CARDIOVASCULAR EFFECTS OF STIMULANTS ON CHILDREN WITH BRAIN TUMOR
por: Khan, Raja, et al.
Publicado: (2020)

QOL-07. The importance of an onco-fertility program for pediatric neuro-oncology patients
por: IJgosse, Irene, et al.
Publicado: (2022)

QOL-01. Inflammatory biomarkers and psychological sequela in pediatric brain tumor survivors
por: Turner, Emily, et al.
Publicado: (2022)

QOL-29. Neuropsychology for you“ – tools to improve awareness of and access to neuropsychological care
por: Weiler-Wichtl, Liesa Josephine, et al.
Publicado: (2022)

QOL-07. CORTICAL VOLUME AND THICKNESS IN ADULT SURVIVORS OF CHILDHOOD POSTERIOR FOSSA TUMORS
por: Sleurs, Charlotte, et al.
Publicado: (2020)

QOL-57. SOUTHERN CALIFORNIA KAISER PERMANENTE PEDIATRIC NEURO-ONCOLOGY PROGRAM DEVELOPMENT
por: Tran, Hung
Publicado: (2020)

QOL-18. A LONGITUDINAL STUDY OF NEUROCOGNITION IN CHILDREN TREATED FOR A BRAIN TUMOR
por: Lemiere, Jurgen, et al.
Publicado: (2020)

QOL-55. INTEGRATED MULTI-SCALE MODEL FOR PEDIATRIC BRAIN TUMOR SURVIVAL PREDICTION
por: Qiu, Yeping Lina, et al.
Publicado: (2020)

QOL-49. THE IMPACT OF OTOTOXICITY AND VISUAL IMPAIRMENT ON EDUCATION IN CHILDREN TREATED FOR CNS TUMOURS
por: Dulson, Harriet, et al.
Publicado: (2020)

QOL-03. Beyond Survival: Clinical Rehabilitation and Functional Optimization Pearls for the Neuro-Oncologist
por: Rosenberg, Nathan
Publicado: (2022)

QOL-31. USE OF PATIENT-REPORTED OUTCOMES TO IDENTIFY YOUTH AT RISK FOR IMPAIRED OVERALL HEALTH
por: Ingerski, Lisa, et al.
Publicado: (2020)

QOL-21. DEVELOPMENT AND UTILISATION OF A NEURO-ONCOLOGY REHABILITATION TEAM: 2018–2019 UPDATE
por: Paisley, Helen, et al.
Publicado: (2020)

QOL-02. PERCEPTIONS OF LATE EFFECTS CARE NEEDS AMONG SURVIVORS OF PEDIATRIC BRAIN TUMOURS
por: Cacciotti, Chantel, et al.
Publicado: (2020)

QOL-12. CLINICAL SIGNIFICANCE OF RADIATION-INDUCED CEREBROVASULAR DISEASE IN CHILDHOOD BRAIN TUMOR SURVIVORS
por: Remes, Tiina, et al.
Publicado: (2020)

QOL-09. SyMon-SAYS: A symptom monitoring and reporting program for children with cancer
por: Lai, Jin-Shei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lq0i9g01c3qj8nng3ue08lu1s9